Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study.

Item

http://www.wikidata.org/entity/Q44167290

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Imatinib in very elderly patie ...... phase: a retrospective study.

@en

Imatinib in very elderly patie ...... phase: a retrospective study.

@nl

type

Item

label

Imatinib in very elderly patie ...... phase: a retrospective study.

@en

Imatinib in very elderly patie ...... phase: a retrospective study.

@nl

prefLabel

Imatinib in very elderly patie ...... phase: a retrospective study.

@en

Imatinib in very elderly patie ...... phase: a retrospective study.

@nl

P1476

Imatinib in very elderly patie ...... phase: a retrospective study.

@en

P2093

Ada D'Addosio

http://www.w3.org/2001/XMLSchema#string

Alessandra Iurlo

http://www.w3.org/2001/XMLSchema#string

Antonella Gozzini

http://www.w3.org/2001/XMLSchema#string

Antonella Russo Rossi

http://www.w3.org/2001/XMLSchema#string

Antonio Spadea

http://www.w3.org/2001/XMLSchema#string

Dario Ferrero

http://www.w3.org/2001/XMLSchema#string

Elisabetta Calistri

http://www.w3.org/2001/XMLSchema#string

Endri Mauro

http://www.w3.org/2001/XMLSchema#string

Enrico Montefusco

http://www.w3.org/2001/XMLSchema#string

Federica Sorà

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

Nomenclature evolution: Changes in the ISCN from the 2005 to the 2009 edition.

Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes.

A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.

Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.

"Real-life" results of front-line treatment with Imatinib in older patients (≥ 65 years) with newly diagnosed chronic myelogenous leukemia.

Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia.

Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score.

P2888

s40266-013-0088-6

P304

629-637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40266-013-0088-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236915895

http://www.w3.org/2001/XMLSchema#string

P698

23681399

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia